FOLH1 and neoplasm: While this may mean that a portion of these tissues remain untargeted directly by PSMA, the irregular “leaky” structures of tumor vasculatures may allow these probes or therapies to infiltrate through the core of the tumor to areas that may show reduced PSMA expression.